Employer overview
Transition Bio has leveraged the experience of world-leading experts in microfluidics, cell imaging and machine learning to establish a one-of-a-kind technology platform to revolutionize condensate drug discovery.
Transition Bio likely engages in research and development efforts aimed at discovering and developing new drugs or biologics, conducting preclinical and clinical studies, and seeking regulatory approvals for its therapeutic candidates.
Biotechnology companies often prioritize innovation and collaboration, working closely with academic institutions, research organizations, and industry partners to advance their scientific discoveries and bring new treatments to patients in need. together science and technology to create novel therapeutics. Transition Bio combines first-of-its-kind microfluidic tools, cellular assays and machine learning to explore chemical space – in vitro, in vivo & in silico – to discover new therapies for diseases driven by biomolecular condensates.